In addition, other polymorphisms were identified in P1, who was found to be heterozygous for the CFHR1/CFHR3 gene deletion and for the MCPggaac atypical HUS allele risk, also in the heterozygous state. This evidence concerns the gene CFHR3 and hemolytic-uremic syndrome.